Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
SaleCommon Stock | 2,000 | $22.43 | $44,860.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $22.40 to $22.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
GrantCommon Stock | 2,000 | $0.93 | $1,860.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,575 Underlying: Common Stock · 2,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
SaleCommon Stock | 2,000 | $22.10 | $44,200.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
GrantCommon Stock | 2,000 | $0.93 | $1,860.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,575 Underlying: Common Stock · 3,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
SaleCommon Stock | 3,000 | $22.06 | $66,180.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.85 to $22.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 21:44 UTC |
JOHNSON BRENTExec. VP of WW Sales & Mktg
|
GrantCommon Stock | 3,000 | $0.93 | $2,790.00 |
DisclosureSEC source: 0000898432-19-001186 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales & Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 17, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,575 Underlying: Common Stock · 2,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 17, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 2,000 | $22.88 | $45,760.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F4 · price: This transaction was executed in multiple trades at prices ranging from $22.74 to $23.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 17, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 2,000 | $0.93 | $1,860.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,575 Underlying: Common Stock · 3,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 3,000 | $21.89 | $65,670.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.15 to $22.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 3,000 | $0.93 | $2,790.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,575 Underlying: Common Stock · 3,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F5 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 3,000 | $21.42 | $64,260.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.25 to $22.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 22:31 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 3,000 | $0.93 | $2,790.00 |
DisclosureSEC source: 0000898432-19-001176 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.25 | $20,250.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.60 | $20,600.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.33 to $20.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.00 | $20,000.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 22:06 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001170 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:40 UTC |
Susi Roger E.Director · Chief Technology Offr, Chmn · 10% owner
|
GiftCommon Stock | 34,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001161 · form4.xml · nonDerivative · entry 1 Susi Roger E. · CIK 0001613801 · Director · Chief Technology Offr, Chmn · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Roger E. Susi Revocable Trust Disclosed balance after: 1,040,800 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 21, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 21, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.62 | $20,620.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 21, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.79 | $20,790.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,375 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $21.21 | $21,210.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 21:29 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001099 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 19, 2019 Filed Aug 23, 2019 22:33 UTC |
McDonnell Leslie LDirector · Chief Exec Officer & Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $21.13 | $0.00 |
DisclosureSEC source: 0000898432-19-001103 · form4.xml · derivative · entry 2 McDonnell Leslie L · CIK 0001728715 · Director · Chief Exec Officer & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-08-19 F3 · derivative.exercise_date: This option was granted on 8/19/2019 and vests over four years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 19, 2019 Filed Aug 23, 2019 22:33 UTC |
McDonnell Leslie LDirector · Chief Exec Officer & Director
|
GrantRestricted Stock Units · Derivative | 94,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001103 · form4.xml · derivative · entry 1 McDonnell Leslie L · CIK 0001728715 · Director · Chief Exec Officer & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,652 Underlying: Common Stock · 94,652 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| August 19, 2019 Filed Aug 28, 2019 21:49 UTC Amendment |
McDonnell Leslie LDirector · Chief Exec Officer & Director
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $21.13 | $0.00 |
DisclosureSEC source: 0000898432-19-001136 · form4.xml · derivative · entry 2 McDonnell Leslie L · CIK 0001728715 · Director · Chief Exec Officer & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-08-19 F3 · derivative.exercise_date: This option was granted on 8/19/2019 and vests over four years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 19, 2019 Filed Aug 28, 2019 21:49 UTC Amendment |
McDonnell Leslie LDirector · Chief Exec Officer & Director
|
GrantRestricted Stock Units · Derivative | 94,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001136 · form4.xml · derivative · entry 1 McDonnell Leslie L · CIK 0001728715 · Director · Chief Exec Officer & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,652 Underlying: Common Stock · 94,652 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on August 19, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.exercise_date: This amendment is being filed to correct the vesting date in footnote 2. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on August 19, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · derivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.98 | $20,980.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · derivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,375 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $20.86 | $20,860.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 21:05 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001098 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 21:45 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001082 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,575 Underlying: Common Stock · 1,000 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 21:45 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 1,000 | $21.10 | $21,100.00 |
DisclosureSEC source: 0000898432-19-001082 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.00 to $21.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 14, 2019 Filed Aug 14, 2019 21:45 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 1,000 | $0.93 | $930.00 |
DisclosureSEC source: 0000898432-19-001082 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. Read SEC document |
| August 13, 2019 Filed Aug 14, 2019 21:45 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001082 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,575 Underlying: Common Stock · 1,800 shares Expires 2021-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.